This initiative is said to be part of the company’s strategic move to cater to the sciences and healthcare industry.
In a press release, DACHSER stated that the service encompasses standard and temperature-controlled air freight, express services, and LCL/FCL sea freight, all backed by GDP certification.
According to DACHSER, the newly launched service aims to address the complex needs of transporting pharmaceutical, biotechnological, medical devices, and other healthcare products.
Rubén Márquez, Business Development Manager of DACHSER Life Science & Healthcare in Iberia ASL, will lead the new service.
Commenting on the announcement, Márquez stated:
“Our understanding of the unique challenges in this sector has driven us to develop a service that ensures critical products reach their destinations safely and efficiently, worldwide. DACHSER Life Science and Healthcare Logistics stands as a trusted partner, providing rapid and secure access to major markets in Asia, America, and Europe,” Márquez stated.